Pelago Bioscience AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pelago Bioscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11277
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pelago Bioscience AB (Pelago Bioscience) is a developer of patented cellular thermal shift assay for use in determination and quantification of drug–target interactions. The company utilizes patented CETSA technology which enables direct, in situ physiologically relevant measurements of target engagement on target proteins in lysate, intact cells and tissue samples. Pelago Bioscience delivers in situ target studies to accelerate the preclinical and clinical drug discovery and diagnostics development. Pelago Bioscience’s services include assay development and screening services, and un-biased proteomic profiling. The company’s CETSA data and applications helps in drug discovery research and development companies to make better and more informed decisions at earlier stages in their projects. Pelago Bioscience is headquartered in Solna, Sweden.

Pelago Bioscience AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pelago Bioscience AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pelago Bioscience AB, Medical Devices Deals, 2012 to YTD 2018 9
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
WuXi AppTec to Partner with Pelago Bioscience 11
Biovica Enters into Agreement with Pelago Bioscience 12
Licensing Agreements 13
Pelago Bioscience Enters into Licensing Agreement with OmicScouts 13
GlaxoSmithKline Enters into Licensing Agreement with Pelago Bioscience for CETSA 14
Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 15
Pelago Bioscience AB – Key Competitors 16
Pelago Bioscience AB – Key Employees 17
Pelago Bioscience AB – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Key Facts 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pelago Bioscience AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pelago Bioscience AB, Deals By Therapy Area, 2012 to YTD 2018 8
Pelago Bioscience AB, Medical Devices Deals, 2012 to YTD 2018 9
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
WuXi AppTec to Partner with Pelago Bioscience 11
Biovica Enters into Agreement with Pelago Bioscience 12
Pelago Bioscience Enters into Licensing Agreement with OmicScouts 13
GlaxoSmithKline Enters into Licensing Agreement with Pelago Bioscience for CETSA 14
Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 15
Pelago Bioscience AB, Key Competitors 16
Pelago Bioscience AB, Key Employees 17

List of Figures
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pelago Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pelago Bioscience AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Pelago Bioscience AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析
    Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • SciClone Pharmaceuticals Inc:企業の戦略的SWOT分析
    SciClone Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Serco Group plc (SRP):企業の財務・戦略的SWOT分析
    Serco Group plc (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Jadason Enterprises Ltd (J03):企業の財務・戦略的SWOT分析
    Jadason Enterprises Ltd (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nippon Yusen Kabushiki Kaisha (9101):石油・ガス:M&Aディール及び事業提携情報
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company. It transports crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes linear trade, air …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Children’s National Health System:医療機器:M&Aディール及び事業提携情報
    Summary Children’s National Health System (CNHS) formerly Children's National Medical Center, is a health care institution which offers pediatric care services. The institution offers pediatric emergency, trauma, neonatal acre, neurosurgery, endocrinology, metabolic diseases and respiratory disorder …
  • BAB, Inc.:企業の戦略・SWOT・財務情報
    BAB, Inc. - Strategy, SWOT and Corporate Finance Report Summary BAB, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Racetrac Petroleum, Inc.
    Racetrac Petroleum, Inc. - Strategy, SWOT and Corporate Finance Report Summary Racetrac Petroleum, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tetra Pak International SA:企業の戦略・SWOT・財務分析
    Tetra Pak International SA - Strategy, SWOT and Corporate Finance Report Summary Tetra Pak International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Australian Broadcasting Corporation:企業の戦略的SWOT分析
    Australian Broadcasting Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Penn National Gaming Inc:企業の戦略・SWOT・財務分析
    Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report Summary Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • United Therapeutics Corporation:企業の戦略・SWOT・財務分析
    United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report Summary United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Huaneng Power International Inc:企業の発電所・SWOT分析2018
    Huaneng Power International Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • Genisphere LLC-製薬・医療分野:企業M&A・提携分析
    Summary Genisphere LLC (Genisphere) is a nanotechnology company which provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapuetics. It develops pipeline produc …
  • Somnomed Ltd (SOM):医療機器:M&Aディール及び事業提携情報
    Summary Somnomed Ltd (SomnoMed) is a medical device company that develops, produces, commercializes and markets devices for the oral treatment of sleep-related disorders. The company’s products include Somnodent, an oral appliance for obstructive sleep apnea; and Somnobrux, a mouthguard that protect …
  • Onduline SA:企業の戦略・SWOT・財務情報
    Onduline SA - Strategy, SWOT and Corporate Finance Report Summary Onduline SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • NEC Capital Solutions Ltd. (8793):企業の財務・戦略的SWOT分析
    NEC Capital Solutions Ltd. (8793) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company offers monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed fo …
  • Tarveda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tarveda Therapeutics Inc (Tarveda), formerly Blend Therapeutics Inc is a clinical stage biopharmaceutical company that discovers and develops miniaturized novel biologic drug conjugates. The company develops targeted anti-cancer medicines for advancing the treatment for solid tumors. Its pip …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆